Related Experiment Videos

ACOG committee opnion: antenatal corticosteroid therapy for fetal maturation

    Insights

    Antenatal corticosteroids like betamethasone are recommended for pregnant women at risk of preterm delivery to aid fetal organ maturation. Repeat courses are not advised outside of clinical trials due to insufficient evidence.

    Area of Science:

    • Obstetrics and Gynecology
    • Neonatal Medicine
    • Pharmacology

    Background:

    • National Institutes of Health consensus conferences in 1994 and 2000 addressed antenatal corticosteroid use.
    • Recommendations focused on women at risk for preterm delivery between 24 and 34 weeks gestation.
    • Betamethasone and dexamethasone are preferred corticosteroids for accelerating fetal organ maturation.

    Purpose of the Study:

    • To summarize consensus recommendations on antenatal corticosteroid therapy.
    • To evaluate the evidence for single versus repeat courses of corticosteroids.
    • To inform clinical practice regarding the use of corticosteroids for preterm birth prevention.

    Main Methods:

    • Review of consensus conference findings and recommendations.
    • Analysis of scientific evidence supporting antenatal corticosteroid use.
    • Consideration of guidelines from professional organizations like ACOG.

    Main Results:

    • A single course of antenatal corticosteroids is recommended for women at risk of preterm delivery within 7 days.
    • Repeat corticosteroid courses, including rescue therapy, are not routinely recommended due to insufficient evidence.
    • Betamethasone and dexamethasone are the most studied and preferred agents.

    Conclusions:

    • Antenatal corticosteroids are beneficial for fetal maturation in cases of preterm delivery risk.
    • Routine use of repeat corticosteroid courses is not supported by current scientific evidence.
    • Clinical trials are recommended for further investigation of repeat corticosteroid therapy.

    Related Concept Videos